Cartilize Inc., a Kyoto-based iPS venture, decides to dissolve

The company, a venture on R&D of iPS cell-derived cartilage, which was formed just 10 months ago, decided during an extraordinary shareholders’ meeting to dissolve.

Nikkei Biotech news release, February 10, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny